Brief: Adaptive Biotechnologies Q4 EPS USD -0.09
05/02/2026 21:05
Feb 05 (Reuters) - Adaptive Biotechnologies Q4 revenue USD 71.681 million vs. IBES estimate USD 59.4 million. Q4 operating expenses USD 84.454 million Q4 operating income USD -12.773 million Q4 net income USD -13.579 million Q4 adjusted EBITDA USD 4.1 million vs. IBES estimate USD -7.45 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile